Literature DB >> 16501410

Long-term evaluation of eccentric viewing spectacles in patients with bilateral central scotomas.

Cornelis A Verezen1, Carina F M Meulendijks, Carel B Hoyng, B Jeroen Klevering.   

Abstract

PURPOSE: Yoked prism spectacles (eccentric viewing spectacles [EVS]) facilitate eccentric viewing in patients with bilateral central scotomas. This study was conducted to evaluate the long-term success and patient satisfaction of this type of low-vision aid. METHODS. In this retrospective cross-sectional study, we reviewed the low-vision rehabilitation records of all patients who received EVS since 1993. With an 18-item survey, 191 patients were questioned about the wearing characteristics, advantages, and disadvantages of the EVS. Descriptive and nonparametric statistics were applied to compare regular users with those persons who no longer use the EVS.
RESULTS: The response rate was 83.2% and the average follow-up time was 4.5 years. Forty percent of all patients still used the EVS. The main disadvantages of these spectacles, mentioned mainly by the nonusers, included the heavy weight (41%), perception of curved lines (46%), dizziness during walking (46%), and poor cosmetic appearance (25%). Many successful long-term users considered the EVS suitable for home activities (86%) and walking in the street (70%) and reported that this device reduced eccentric viewing (77%), created better vision in the center of their visual field (67%), and helped with recognition of objects and faces (64%).
CONCLUSIONS: The prescription of EVS aids eccentric viewing in patients with dense central scotomas. Although associated with a number of disadvantages and side effects, 40% of the patients continued to use EVS. The results of this study indicate that patients who experience difficulties with eccentric fixation are most likely to benefit from these low-vision aids. A thorough explanation of the advantages and disadvantages of the EVS is important to prevent unnecessary disappointments.

Entities:  

Mesh:

Year:  2006        PMID: 16501410     DOI: 10.1097/01.opx.0000200679.81892.d4

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  Clinical and laboratory evaluation of peripheral prism glasses for hemianopia.

Authors:  Robert G Giorgi; Russell L Woods; Eli Peli
Journal:  Optom Vis Sci       Date:  2009-05       Impact factor: 1.973

Review 2.  Topical Review: Assessment of Binocular Sensory Processes in Low Vision.

Authors:  Janelle Tong; Jessie Huang; Vincent Khou; Jodi Martin; Michael Kalloniatis; Angelica Ly
Journal:  Optom Vis Sci       Date:  2021-04-01       Impact factor: 2.106

3.  Scotoma Simulation in Healthy Subjects.

Authors:  Sascha Klee; Dietmar Link; Stefan Sinzinger; Jens Haueisen
Journal:  Optom Vis Sci       Date:  2018-12       Impact factor: 1.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.